On September 17, 2019, IDL Biotech will launch the company’s rapid test for typhoid fever, TUBEX TF, in Kenya.
Read more here
On September 17, 2019, IDL Biotech will launch the company’s rapid test for typhoid fever, TUBEX TF, in Kenya.
Read more here
On March 9, AroCell, Anders Hultman CEO, presented the latest developments and the future of the company at the Stockholm Corporate Finance Life Science Capital Markets Days at the IVA conference center in Stockholm. Stockholm Corporate Finance arranged the capital...
IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company...
IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF. Since its launch in Africa, the company has focused on finding the right partners for...